President Biden on Pharmaceutical R&D Costs

Posted: 2025-05-14 08:55:30 UTC

@Rapid Response 47RapidResponse47

#Biden

#Healthcare

#Pharmaceuticals

#POTUS

#R&D

Read With Caution

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Full Thread

This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.

Read With Caution

Verification Details

Status

In Progress

VerifiedPartially VerifiedFalse

Last Updated

2025-05-14 08:55:39 UTC

Verified By

Rollup News

TL;DR;

President Biden addresses the issue of pharmaceutical companies claiming high research and development costs, which were disproportionately borne by America. He asserts that this will no longer be the case.

Key Impact Areas

Pharmaceutical companies' R&D costs

Financial burden on America

Policy change

Challenges

High pharmaceutical research and development costs

Disproportionate financial burden on American consumers

President Biden on Pharmaceutical R&D Costs

Read With Caution

Full Thread

Read With Caution

Verification Details

TL;DR;

Key Impact Areas

Challenges

Claims

Deliberation Map

Similar Rollups